XML 24 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 29, 2018
Dec. 29, 2017
Current assets:    
Cash and cash equivalents $ 248,407 $ 183,164 [1]
Short-term investments 251,516 204,607 [1]
Short-term restricted cash and investments 504 504 [1]
Trade and other receivables 167,161 81,192 [1]
Inventory, net 8,371 6,657 [1]
Prepaid expenses and other current assets 10,327 8,750 [1]
Total current assets 686,286 484,874 [1]
Long-term investments 94,396 64,255 [1]
Long-term restricted cash and investments 1,100 4,646 [1]
Property and equipment, net 64,744 25,743 [1]
Goodwill 63,684 63,684 [1]
Other long-term assets 948 12,092 [1]
Total assets 911,158 655,294 [1]
Current liabilities:    
Accounts payable 13,023 9,575 [1]
Accrued compensation and benefits 21,538 21,073 [1]
Accrued clinical trial liabilities 16,801 19,849 [1]
Rebates and fees due to customers 11,143 7,565 [1]
Accrued collaboration liabilities 7,713 8,974 [1]
Current portion of deferred revenue 5,939 31,984 [1]
Other current liabilities 23,787 16,150 [1]
Total current liabilities 99,944 115,170 [1]
Long-term portion of deferred revenue 11,970 238,520 [1]
Financing obligation for build-to-suit lease 20,646 14,530
Other long-term liabilities 3,630 2,113 [1]
Total liabilities 136,190 370,333 [1]
Commitments [1]
Stockholders’ equity    
Preferred stock, $0.001 par value, 10,000,000 shares authorized and no shares issued 0 0 [1]
Common stock, $0.001 par value; 400,000,000 shares authorized; issued and outstanding: 295,700,576 and 289,923,798 at September 30, 2017 and December 31, 2016, respectively 298 296 [1]
Additional paid-in capital 2,142,717 2,114,184 [1]
Accumulated other comprehensive loss (731) (347) [1]
Accumulated deficit (1,367,316) (1,829,172) [1]
Total stockholders’ equity 774,968 284,961 [1]
Total liabilities and stockholders’ equity $ 911,158 $ 655,294 [1]
[1] The Condensed Consolidated Balance Sheet as of December 31, 2017 has been derived from the audited financial statements as of that date.